Contraception

The Division of Family Planning and Preventive Services has many active clinical trials involving the development and assessment of contraceptive methods; these studies range from Phase I to Phase IV. We also study approaches to improved abortion care and innovations in reproductive health screening.

The Division participates in the Contraceptive Clinical Trials Network (CCTN) of the National Institute of Health, developing new contraceptive products. All of our research is patient-centered and is designed to bring contraceptive innovations to patients as quickly as possible. Ongoing trials in the CCTN include:

• Clinical evaluation of levonorgestrel butanoate for injectable contraception
• Evaluation of a hormone-free vaginal ring for contraception

The Division is also home to pilot studies, foundation sponsored projects, as well as larger multi-center trials funded by NIH and industry sponsors. Current and recent trials include:

• Efficacy, safety, and tolerability of a novel copper intrauterine device 
• An exploratory study of intrauterine devices removed in the operating room 
• Contraceptive efficacy and safety of a low-dose contraceptive patch 
• Evaluation of mifepristone and misoprostol for miscarriage management 
• An exploratory analysis of patient perspectives regarding the Title XIX Sterilization Consent Form 
• Safety and effectiveness of Essure™ Model 505
• Bilateral tubal occlusive trial for female permanent contraception
• Contraceptive efficacy and safety of etonogestrel (MK-8415) implant during extended use from 3 years after insertion in females 35 years of age or younger

Faculty Active in this Area

• Paula Castaño, MD, MPH
• Erika Levi, MD

Contact Us:

Jolene Lalas, MPH, Ed.D, CCRC; Clinical Research Manager

 jrl2142@cumc.columbia.edu, 212-305-9672 

For more information on actively-recruiting studies, visit: RecruitMe